Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (206K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Klumpp, K.
Right arrow Articles by Martin, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klumpp, K.
Right arrow Articles by Martin, J. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2003, Vol. 31, No. 23 6852-6859
© 2003 Oxford University Press


Article

Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors

Klaus Klumpp*,1,2, Julie Qi Hang2, Surendran Rajendran2, Yanli Yang2, Andre Derosier2, Philippe Wong Kai In1, Hilary Overton1, Kevin E. B. Parkes1,2, Nick Cammack1,2 and Joseph A. Martin1,2

1 Roche Discovery Welwyn, Welwyn Garden City, UK and 2 Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, CA 94304, USA

*To whom correspondence should be addressed at Roche Palo Alto LLC, Mail Stop S3-1, 3431 Hillview Avenue, Palo Alto, CA 94304, USA. Tel: +1 650 855 6028; Fax: +1 650 354 7554; Email: klaus.klumpp{at}roche.com
Present addresses:
Philippe Wong Kai In and Hilary Overton, OSI Pharmaceuticals, Oxford, UK
Kevin E. B. Parkes, Medivir AB, Cambridge, UK

Human immunodeficiency virus (HIV) RNase H activity is essential for the synthesis of viral DNA by HIV reverse transcriptase (HIV-RT). RNA cleavage by RNase H requires the presence of divalent metal ions, but the role of metal ions in the mechanism of RNA cleavage has not been resolved. We measured HIV RNase H activity associated with HIV-RT protein in the presence of different concentrations of either Mg2+, Mn2+, Co2+ or a combination of these divalent metal ions. Polymerase-independent HIV RNase H was similar to or more active with Mn2+ and Co2+ compared with Mg2+. Activation of RNase H by these metal ions followed sigmoidal dose–response curves suggesting cooperative metal ion binding. Titration of Mg2+-bound HIV RNase H with Mn2+ or Co2+ ions generated bell-shaped activity dose–response curves. Higher activity could be achieved through simultaneous binding of more than one divalent metal ion at intermediate Mn2+ and Co2+ concentrations, and complete replacement of Mg2+ occurred at higher Mn2+ or Co2+ concentrations. These results are consistent with a two-metal ion mechanism of RNA cleavage as previously suggested for a number of polymerase-associated nucleases. In contrast, the structurally highly homologous RNase HI from Escherichia coli is most strongly activated by Mg2+, is significantly inhibited by submillimolar concentrations of Mn2+ and most probably cleaves RNA via a one-metal ion mechanism. Based on this difference in active site structure, a series of small molecule N-hydroxyimides was identified with significant enzyme inhibitory potency and selectivity for HIV RNase H.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
R. M. Yarrington, J. Chen, E. C. Bolton, and J. D. Boeke
Mn2+ Suppressor Mutations and Biochemical Communication between Ty1 Reverse Transcriptase and RNase H Domains
J. Virol., September 1, 2007; 81(17): 9004 - 9012.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
V. Goldschmidt, J. Didierjean, B. Ehresmann, C. Ehresmann, C. Isel, and R. Marquet
Mg2+ dependency of HIV-1 reverse transcription, inhibition by nucleoside analogues and resistance
Nucleic Acids Res., January 3, 2006; 34(1): 42 - 52.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J. Didierjean, C. Isel, F. Querre, J.-F. Mouscadet, A.-M. Aubertin, J.-Y. Valnot, S. R. Piettre, and R. Marquet
Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase, RNase H, and Integrase Activities by Hydroxytropolones
Antimicrob. Agents Chemother., December 1, 2005; 49(12): 4884 - 4894.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. R. Budihas, I. Gorshkova, S. Gaidamakov, A. Wamiru, M. K. Bona, M. A. Parniak, R. J. Crouch, J. B. McMahon, J. A. Beutler, and S. F. J. Le Grice
Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones
Nucleic Acids Res., March 1, 2005; 33(4): 1249 - 1256.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
W. Sun, A. Pertzev, and A. W. Nicholson
Catalytic mechanism of Escherichia coli ribonuclease III: kinetic and inhibitor evidence for the involvement of two magnesium ions in RNA phosphodiester hydrolysis
Nucleic Acids Res., February 7, 2005; 33(3): 807 - 815.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.